Drug Drop Test: How to Quickly Identify Potential Therapeutic Compounds for Mitochondrial Diseases Using Yeast Saccharomyces cerevisiae
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241310696 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Martina Magistrati und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parco Area delle Scienze 11/A, 43124 Parma, Italy. Hauptthemen laut MEDLINE: Mitochondrial Diseases, Saccharomyces cerevisiae Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 258 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ‘Departments of Excellence’ program of the Italian Ministry for Education, University and Research, MUR, Fondazione Telethon.
Abstract (Originalsprache)
Mitochondrial diseases (MDs) refer to a group of clinically and genetically heterogeneous pathologies characterized by defective mitochondrial function and energy production. Unfortunately, there is no effective treatment for most MDs, and current therapeutic management is limited to relieving symptoms. The yeast Saccharomyces cerevisiae has been efficiently used as a model organism to study mitochondria-related disorders thanks to its easy manipulation and well-known mitochondrial biogenesis and metabolism. It has been successfully exploited both to validate alleged pathogenic variants identified in patients and to discover potential beneficial molecules for their treatment. The so-called “drug drop test”, a phenotype-based high-throughput screening, especially if coupled with a drug repurposing approach, allows the identification of molecules with high translational potential in a cost-effective and time-saving manner. In addition to drug identification, S. cerevisiae can be used to point out the drug’s target or pathway. To date, drug drop tests have been successfully carried out for a variety of disease models, leading to very promising results. The most relevant aspect is that studies on more complex model organisms confirmed the effectiveness of the drugs, strengthening the results obtained in yeast and demonstrating the usefulness of this screening as a novel approach to revealing new therapeutic molecules for MDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parco Area delle Scienze 11/A, 43124 Parma, Italy.
ORCID-Profile: Martina Magistrati, Maria Carla Gerra, Enrico Baruffini, Cristina Dallabona
Förderung
- ‘Departments of Excellence’ program of the Italian Ministry for Education, University and Research
- MUR
- Fondazione Telethon
Zitieren
APA
Magistrati, M., Gilea, A. I., Gerra, M. C., Baruffini, E., & Dallabona, C. (2023). Drug Drop Test: How to Quickly Identify Potential Therapeutic Compounds for Mitochondrial Diseases Using Yeast Saccharomyces cerevisiae. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241310696
Vancouver
Magistrati M, Gilea AI, Gerra MC, Baruffini E, Dallabona C. Drug Drop Test: How to Quickly Identify Potential Therapeutic Compounds for Mitochondrial Diseases Using Yeast Saccharomyces cerevisiae. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241310696
BibTeX
@article{Magistrati2023,
author = {Magistrati, Martina and Gilea, Alexandru Ionut and Gerra, Maria Carla and Baruffini, Enrico and Dallabona, Cristina},
title = {Drug Drop Test: How to Quickly Identify Potential Therapeutic Compounds for Mitochondrial Diseases Using Yeast Saccharomyces cerevisiae},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241310696}
}
EUVIMED